Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis

Glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase, is a vital glycogen synthase regulator controlling glycogen synthesis, glucose metabolism, and insulin signaling. GSK-3 is widely expressed in different types of cells, and its abundant roles in cellular bioregulation have been speculate...

Full description

Bibliographic Details
Main Authors: Chia-Ling Chen, Po-Chun Tseng, Rahmat Dani Satria, Thi Thuy Nguyen, Cheng-Chieh Tsai, Chiou-Feng Lin
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/9/4669
_version_ 1797504644428070912
author Chia-Ling Chen
Po-Chun Tseng
Rahmat Dani Satria
Thi Thuy Nguyen
Cheng-Chieh Tsai
Chiou-Feng Lin
author_facet Chia-Ling Chen
Po-Chun Tseng
Rahmat Dani Satria
Thi Thuy Nguyen
Cheng-Chieh Tsai
Chiou-Feng Lin
author_sort Chia-Ling Chen
collection DOAJ
description Glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase, is a vital glycogen synthase regulator controlling glycogen synthesis, glucose metabolism, and insulin signaling. GSK-3 is widely expressed in different types of cells, and its abundant roles in cellular bioregulation have been speculated. Abnormal GSK-3 activation and inactivation may affect its original bioactivity. Moreover, active and inactive GSK-3 can regulate several cytosolic factors and modulate their diverse cellular functional roles. Studies in experimental liver disease models have illustrated the possible pathological role of GSK-3 in facilitating acute hepatic injury. Pharmacologically targeting GSK-3 is therefore suggested as a therapeutic strategy for liver protection. Furthermore, while the signaling transduction of GSK-3 facilitates proinflammatory interferon (IFN)-γ in vitro and in vivo, the blockade of GSK-3 can be protective, as shown by an IFN-γ-induced immune hepatitis model. In this study, we explored the possible regulation of GSK-3 and the potential relevance of GSK-3 blockade in IFN-γ-mediated immune hepatitis.
first_indexed 2024-03-10T04:07:19Z
format Article
id doaj.art-84707c83e1ac42a09849b5f2b8aa0b0c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:07:19Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-84707c83e1ac42a09849b5f2b8aa0b0c2023-11-23T08:20:34ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01239466910.3390/ijms23094669Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune HepatitisChia-Ling Chen0Po-Chun Tseng1Rahmat Dani Satria2Thi Thuy Nguyen3Cheng-Chieh Tsai4Chiou-Feng Lin5School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, TaiwanCore Laboratory of Immune Monitoring, Office of Research & Development, Taipei Medical University, Taipei 110, TaiwanInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, TaiwanInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, TaiwanDepartment of Nursing, Chung Hwa University of Medical Technology, Tainan 703, TaiwanCore Laboratory of Immune Monitoring, Office of Research & Development, Taipei Medical University, Taipei 110, TaiwanGlycogen synthase kinase-3 (GSK-3), a serine/threonine kinase, is a vital glycogen synthase regulator controlling glycogen synthesis, glucose metabolism, and insulin signaling. GSK-3 is widely expressed in different types of cells, and its abundant roles in cellular bioregulation have been speculated. Abnormal GSK-3 activation and inactivation may affect its original bioactivity. Moreover, active and inactive GSK-3 can regulate several cytosolic factors and modulate their diverse cellular functional roles. Studies in experimental liver disease models have illustrated the possible pathological role of GSK-3 in facilitating acute hepatic injury. Pharmacologically targeting GSK-3 is therefore suggested as a therapeutic strategy for liver protection. Furthermore, while the signaling transduction of GSK-3 facilitates proinflammatory interferon (IFN)-γ in vitro and in vivo, the blockade of GSK-3 can be protective, as shown by an IFN-γ-induced immune hepatitis model. In this study, we explored the possible regulation of GSK-3 and the potential relevance of GSK-3 blockade in IFN-γ-mediated immune hepatitis.https://www.mdpi.com/1422-0067/23/9/4669glycogen synthase kinase-3immune hepatitisinterferon-γliver
spellingShingle Chia-Ling Chen
Po-Chun Tseng
Rahmat Dani Satria
Thi Thuy Nguyen
Cheng-Chieh Tsai
Chiou-Feng Lin
Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
International Journal of Molecular Sciences
glycogen synthase kinase-3
immune hepatitis
interferon-γ
liver
title Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
title_full Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
title_fullStr Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
title_full_unstemmed Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
title_short Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
title_sort role of glycogen synthase kinase 3 in interferon γ mediated immune hepatitis
topic glycogen synthase kinase-3
immune hepatitis
interferon-γ
liver
url https://www.mdpi.com/1422-0067/23/9/4669
work_keys_str_mv AT chialingchen roleofglycogensynthasekinase3ininterferongmediatedimmunehepatitis
AT pochuntseng roleofglycogensynthasekinase3ininterferongmediatedimmunehepatitis
AT rahmatdanisatria roleofglycogensynthasekinase3ininterferongmediatedimmunehepatitis
AT thithuynguyen roleofglycogensynthasekinase3ininterferongmediatedimmunehepatitis
AT chengchiehtsai roleofglycogensynthasekinase3ininterferongmediatedimmunehepatitis
AT chioufenglin roleofglycogensynthasekinase3ininterferongmediatedimmunehepatitis